Gelesis | 8-K: Current report
Gelesis | CT ORDER: Confidential Treatment Order
Gelesis | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-PureTech Health LLC(92.5%),PureTech Health plc(92.5%)
Gelesis | 8-K: Current report
Gelesis | SC 13E3/A: Schedule filed to report going private transactions (Amendment)
Gelesis | PRER14A: Preliminary revised proxy soliciting materials
Gelesis | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-PureTech Health LLC(92.5%),PureTech Health plc(92.5%)
Gelesis | 4: Statement of changes in beneficial ownership of securities-10% Owner PureTech Health plc
Gelesis | 8-K: Current report
Gelesis | SC 13E3/A: Schedule filed to report going private transactions (Amendment)
Gelesis | PRER14A: Preliminary revised proxy soliciting materials
Gelesis | 8-K: Current report
Gelesis | 8-K: Current report
Gelesis | 10-Q: Q2 2023 Earnings Report
Gelesis | SC 13E3: Schedule filed to report going private transactions
Gelesis | PREM14A: Preliminary proxy statements relating to merger or acquisition
Gelesis | 8-K: Current report
Gelesis | DEFA14A: Others
Gelesis | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)
Gelesis | 8-K: Current report
Unlock the Full List